Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Optimal environment to natural, personal and professional development leading to the making of responsible citizens. The day begins in the holy and spiritual environment with a prayer. Complete discipline, unfitness and the unity brought to be attained thought a dress code for staff members and students.
